Deal Announcements

23andMe Raises $22 Million Venture Capital Funding

Wednesday, November 10, 2010 5:33:00 AM PDT | VentureDeal Staff

   Mountain View, California  --  Genetic testing company 23andMe has secured $22 million in its third round of venture capital investment.

23andMe operates a service that allows individuals to have their DNA tested for potential future health conditions.

Venture capital firm New Enterprise Associates invested along with corporate venture capital arms Johnson & Johnson Development Corporation and Google Ventures.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1